#Serum_Institute_of_India #Cervical_Cancer #QHPV_ Vaccine #Adar_Poona_Walla

Serum Institute of India CEO Adar Poona Walla said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year. The Drugs Controller General of India granted market authorization to Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer.

Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Website: [ Ссылка ]

свернуть